Biotech news
Biotech
Both companies have agreed to dismiss claims and counterclaims involving Amgen’s 2 mg aflibercept biosimilar, while their wider feud continues. 28 October 2026
Biotech
Following the Federal Circuit’s decision to uphold the invalidation of three patents, the parties are set to drop their remaining claims, despite 10x’s separate multi-million dollar jury win. 23 October 2026
.jpg/r%5Bwidth%5D=1280&r%5Bheight%5D=720/30268560-c97a-11f1-b7d1-f52eb995587f-Untitled%20design%20(16).webp)
Biotech
All 30 claims of a key DNA sequencing patent have been upheld for a second time, marking another setback in a long-running dispute that has already left Guardant facing a $245 million bill. 16 October 2026
Careers
Growing demand from life sciences and healthcare clients prompts an expansion in California, bringing the firm closer to biotechnology companies, research institutions and key courts for its Southern California litigators. 14 October 2026
In-house counsel
With patent validity increasingly being fought over in both the UPC and EPO, Genevant Sciences’ Stephan Kutik talks to LSIPR about keeping parallel proceedings aligned and why teamwork matters. 1 October 2026
Biotech
The gene-editing company has accused a former employee of secretly co-founding a Chinese biotech while still at the company, in a trade secrets lawsuit involving rival base-editing therapies and disputed patent filings. 29 September 2026
Careers
Varnum appoints the new partner to its litigation and ADR practice team as a partner in Michigan, bringing industry expertise in software, medical devices, robotics, consumer electronics and more. 23 September 2026
Biotech
Judges agreed with the Oxford University spin-out that MGI Tech was likely to infringe Oxford’s patent, and banned sales of certain Cyclone devices to preserve the one-player-market status quo. 21 September 2026
Careers
The new hire brings more than two decades’ experience managing complex cross-border disputes in life sciences and technology, including most recently at the Unified Patent Court. 18 September 2026
Pharma
Bauer Research Foundation has alleged that the CDMO misappropriated its confidential manufacturing know-how related to NO-Cbl, an anticancer drug candidate in the pre-clinical/translational stage of development for potential human use. 17 September 2026